CompletedNot Applicable

Cardiac Neuromodulation for Heart Failure

Poland34 participantsStarted 2020-12-15

Plain-language summary

This investigation will evaluate the ability of the Moderato® System to safely and effectively deliver CNT, to reduce sympathetic activity in heart failure patients

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Subject is ≥ 18 years of age
. Subject has a primary indication and is scheduled for ICD implantation or replacement
. Subject has heart failure NYHA Class II or III

Exclusion criteria

. Subject is to receive a single chamber defibrillator
. Subject has an ejection fraction of 25% or less
. Subject's systolic blood pressure is less than 120 mm Hg on the day of implant
. Subject has decompensated heart failure
. Subject has significant (\>2+) mitral regurgitation, aortic regurgitation or aortic stenosis.
. Subject has permanent atrial fibrillation
. Subject has atrial fibrillation on the day of the study.
. Subject has hypertrophic cardiomyopathy, restrictive cardiomyopathy or interventricular septal thickness ≥15 mm

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Arterial Elastance

Timeframe: Immediate, derived form ongoing Pressure Volume changes in the Left ventricle

Trial details

NCT IDNCT04573699

SponsorBackBeat Medical Inc

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-12-15

View on ClinicalTrials.gov More Heart Failure NYHA Class II trials